0001209191-19-011841.txt : 20190220 0001209191-19-011841.hdr.sgml : 20190220 20190220203746 ACCESSION NUMBER: 0001209191-19-011841 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190219 FILED AS OF DATE: 20190220 DATE AS OF CHANGE: 20190220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelly Thomas Patrick CENTRAL INDEX KEY: 0001410514 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38219 FILM NUMBER: 19620294 MAIL ADDRESS: STREET 1: 60 WESTVIEW STREET CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Deciphera Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001654151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200299725 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 TOTTEN POND ROAD CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-209-6400 MAIL ADDRESS: STREET 1: 500 TOTTEN POND ROAD CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Deciphera Pharmaceuticals, LLC DATE OF NAME CHANGE: 20150928 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-19 0 0001654151 Deciphera Pharmaceuticals, Inc. DCPH 0001410514 Kelly Thomas Patrick C/O DECIPHERA PHARMACEUTICALS, INC. 500 TOTTEN POND ROAD WALTHAM MA 02451 0 1 0 0 Chief Financial Officer Common Stock 2019-02-19 4 M 0 1500 1.89 A 1500 D Common Stock 2019-02-19 4 S 0 1500 30.00 D 0 D Stock Option (Right to Buy) 1.89 2019-02-19 4 M 0 1500 0.00 D 2025-12-17 Common Stock 1500 166508 D The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option vests in 16 equal installments over a 4-year period following the vesting commencement date of 2/23/2015, subject to continued service through such dates. /s/ Thomas P. Kelly 2019-02-20